Perceptions of acceptability and preferences surrounding a hypothetical syphilis vaccine in Lima, Peru

BackgroundNo vaccine is currently available for syphilis. Research efforts to inform vaccine development are underway. In parallel, understanding factors that would influence willingness to receive a future vaccine can provide useful information for vaccine design and future implementation. This study explored attributes of interest in a hypothetical syphilis vaccine using focus group discussions in Lima, Peru.MethodsIn early 2025, we conducted ten virtual focus group discussions, among five population groups in Lima, Peru: health professionals, sexual/gender minorities, general population, cisgender female sex workers, and parents of minors. Semi-structured guides explored barriers and facilitators to preventive care, attitudes toward vaccines, syphilis knowledge, and desired attributes of a potential syphilis vaccine. Audio recordings were analyzed thematically.ResultsEighty-five participants took part in the discussions. Despite limited syphilis knowledge among many participants, there was interest in a hypothetical vaccine. Acceptability was shaped by three factors including, vaccine attributes, structural conditions and the healthcare provider-user relationship. In vaccine attributes, participants desired high effectiveness, safety, and a single-dose schedule, while expressing concerns about vaccine-induced persistent seropositivity related to stigma about STI prevention. Structural conditions: free vaccination, endorsement from respected health institutions, information environment and health education were viewed as essential for uptake. Third, the healthcare provider-user relationship emerged as a central mediator influencing how individuals interpreted vaccine information and navigated structural barriers.ConclusionsAcceptability of a future syphilis vaccine depends not only on its attributes, but also on structural enablers and the quality of provider-user interactions. Strengthening provider communication, addressing structural barriers, and ensuring transparent information dissemination will be essential for equitable implementation.

Authors

Institutions

Publication Details

Journal
International Journal of STD & AIDS
Published
2026-06-12
DOI
https://doi.org/10.1177/09564624261459952
Primary Topic
Syphilis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Perceptions of acceptability and preferences surrounding a hypothetical syphilis vaccine in Lima, Peru

Kelika Anne Konda, Jessica Pérez, Jeffrey David Klausner, Gilbert A. Orta Portillo et al.
International Journal of STD & AIDS
Syphilis Diagnosis and Treatment
article

Perceptions of acceptability and preferences surrounding a hypothetical syphilis vaccine in Lima, Peru

Kelika Anne Konda, Jessica Pérez, Jeffrey David Klausner, Gilbert A. Orta Portillo, Wendy Hamasaki, Valeria Fulqui
article en

Abstract

BackgroundNo vaccine is currently available for syphilis. Research efforts to inform vaccine development are underway. In parallel, understanding factors that would influence willingness to receive a future vaccine can provide useful information for vaccine design and future implementation. This study explored attributes of interest in a hypothetical syphilis vaccine using focus group discussions in Lima, Peru.MethodsIn early 2025, we conducted ten virtual focus group discussions, among five population groups in Lima, Peru: health professionals, sexual/gender minorities, general population, cisgender female sex workers, and parents of minors. Semi-structured guides explored barriers and facilitators to preventive care, attitudes toward vaccines, syphilis knowledge, and desired attributes of a potential syphilis vaccine. Audio recordings were analyzed thematically.ResultsEighty-five participants took part in the discussions. Despite limited syphilis knowledge among many participants, there was interest in a hypothetical vaccine. Acceptability was shaped by three factors including, vaccine attributes, structural conditions and the healthcare provider-user relationship. In vaccine attributes, participants desired high effectiveness, safety, and a single-dose schedule, while expressing concerns about vaccine-induced persistent seropositivity related to stigma about STI prevention. Structural conditions: free vaccination, endorsement from respected health institutions, information environment and health education were viewed as essential for uptake. Third, the healthcare provider-user relationship emerged as a central mediator influencing how individuals interpreted vaccine information and navigated structural barriers.ConclusionsAcceptability of a future syphilis vaccine depends not only on its attributes, but also on structural enablers and the quality of provider-user interactions. Strengthening provider communication, addressing structural barriers, and ensuring transparent information dissemination will be essential for equitable implementation.

International Journal of STD & AIDS
University of Southern California (US), Universidad Peruana Cayetano Heredia (PE), California Southern University (US)
Gender equality
Openalex Percentile: Top 6%
Syphilis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.